Mosebrook Jeffrey

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$613,635.90

Insider Activity of Mosebrook Jeffrey

According to the SEC Form 4 filings, Mosebrook Jeffrey, being in a position of

  1. SVP, Fin & Princ Acct Officer at Integra LifeSciences Holdings Corporation,
    оver the last 12 months, has bought 0 shares, and sold 1191 share for $25,701,
    over all time since 2017-11-20, has bought 0 shares, and sold 12192 shares for $613,636.

The largest sale of all time was on 2019-07-30 and amounted to 2358 shares of Integra LifeSciences Holdings Corporation for $149,387.

Biography of Mosebrook Jeffrey

No biography is available at this moment.

2024-08-19SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
1,191
0.0015%
$21.58$25,701-5.57%
2023-08-09SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & PAO
1,177
0.0014%
$44.46$52,329-14.14%
2022-12-08SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
279
0.0003%
$56.22$15,684-21.21%
2022-08-02SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
437
0.0005%
$56.77$24,811-5.27%
2021-11-10SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
700
0.0008%
$70.88$49,616-13.98%
2021-03-02SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
2,116
0.0012%
$34.35$72,684-0.82%
2020-08-13SaleIntegra LifeSciences Holdings Corporation
IART
SVP, Fin & Princ Acct Officer
1,614
0.0019%
$51.68$83,417+30.25%
2019-07-30SaleIntegra LifeSciences Holdings Corporation
IART
Principal Accounting Officer
2,358
0.0027%
$63.35$149,387-11.18%
2018-08-10SaleIntegra LifeSciences Holdings Corporation
IART
Principal Accounting Officer
2,000
0.0023%
$62.42$124,835-14.06%
2017-11-20SaleIntegra LifeSciences Holdings Corporation
IART
Principal Accounting Officer
320
0.0004%
$47.41$15,172+24.35%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.